Financial statements IFRS 120 285 Aviva plc 145 Annual Report and Accounts 2008 Overview Business review Governance Financial statements IFRS Financial statements MCEV Consolidated cash flow statement Other information For the year ended 31 December 2008 The cash flows presented in this statement cover all the Groups activities and include flows from both policyholder and shareholder activities.
Non-longLong-term term Restated business business Total Total operations operations 2008 2007 Note m m m m Cash flows from operating activities 52a Cash-generated from operations 7,920 875 8,795 4,944 Tax paid 394 248 642 801 Net cash from operating activities 7,526 627 8,153 4,143 Cash flows from investing activities Acquisitions of subsidiaries, joint ventures and associates, net of cash acquired 52b 93 243 336 769 Disposals of subsidiaries, joint ventures and associates, net of cash transferred 52c 180 173 353 283 Purchase of minority interest in subsidiary 65 65 New loans to joint ventures and associates 182 182 126 Repayment of loans to joint ventures and associates 52 52 159 Net repayment loans to joint ventures and associates 18a & 19a 130 130 33 Purchases of property and equipment 20 57 159 216 227 Proceeds on sale of property and equipment 35 24 59 93 Purchases of intangible assets 17 34 26 60 48 Net cash used in investing activities 164 231 395 635 Cash flows from financing activities Proceeds from issue of ordinary shares, net of transaction costs 20 20 48 Treasury shares purchased for employee trusts 29 29 10 New borrowings drawn down, net expenses 1,435 4,080 5,515 6,322 Repayment of borrowings 1,365 3,852 5,217 6,000 Net drawdown of borrowings 47e 70 228 298 322 Interest paid on borrowings 712 825 1,537 1,208 Preference dividends paid 17 17 17 Ordinary dividends paid 732 732 500 Coupon payments on direct capital instrument 56 56 53 Finance lease payments 14 14 7 Capital contributions from minority shareholders 36 36 307 Dividends paid to minority interests of subsidiaries 83 23 106 66 Non-trading cash flows between operations 189 189 Net cash from financing activities 878 1,259 2,137 1,184 Net increase in cash and cash equivalents 6,484 863 5,621 2,324 Cash and cash equivalents at 1 January 11,132 4,432 15,564 12,635 Effect of exchange rate changes on cash and cash equivalents 2,525 359 2,884 605 Cash and cash equivalents at 31 December 20,141 3,928 24,069 15,564 Of the total cash and cash equivalents, 493 million 2007: 96 million was classified as held for sale see note 3c.
Cash and cash equivalents in long-term business operations of 20,141 million 2007: 11,132 million are primarily held for the benefit of policyholders and so are generally not available for use by the Group.
The accounting policies identified alphabetically on pages 125 to 139 and notes identified numerically on pages 146 to 277 are an integral part of these financial statements.
